Acromegaly

Posted 2 weeks ago by Wales Gene Park

Brief Summary: The purpose of this trial is to assess the efficacy and safety of CAM2029 in patients with acromegaly. Patients will be randomized to either CAM2029 or placebo administered subcutaneously once monthly during 6 months.

 Acromegaly /  Manchester


No post found